Apolipoprotein E promoter polymorphisms do not have a major influence on the risk of developing primary open angle glaucoma

Molecular Vision

Volumn 10, Issue , 2004, Pages 805-807

  Ressiniotis, Thomas ^a,b   Griffiths, Philip G ^a   Birch, Michael ^a   Keers, Sharon M ^b   Chinnery, Patrick F ^b  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; PRIMER DNA;

ARTICLE; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; OPEN ANGLE GLAUCOMA; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; AGED; CHEMISTRY; FEMALE; GENETICS; INTRAOCULAR PRESSURE; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RISK FACTOR;

AGED; APOLIPOPROTEINS E; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; FEMALE; GENOTYPE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RISK FACTORS;

EID: 16644395538     PISSN: 10900535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Quigley HA. Open-angle glaucoma. N Engl J Med 1993; 328:1097-106.
2. Lichter PR. Genetic clues to glaucoma's secrets. The L Edward Jackson Memorial Lecture. Part 2. Am J Ophthalmol 1994; 117:706-27.
3. WuDunn D. Genetic basis of glaucoma. Curr Opin Ophthalmol 2002; 13:55-60.
4. Adam MF, Belmouden A, Binisti P, Brezin AP, Valtot F, Bechetoille A, Dascotte JC, Copin B, Gomez L, Chaventre A, Bach JF, Garchon HJ. Recurrent mutations in a single exon encoding the evolutionarily conserved olfactomedin-homology domain of TIGR in familial open-angle glaucoma. Hum Mol Genet 1997; 6:2091-7.
5. Bedlack RS, Strittmatter WJ, Morgenlander JC. Apolipoprotein E and neuromuscular disease: a critical review of the literature. Arch Neurol 2000; 57:1561-5.
6. Bayer AU, Keller ON, Ferrari F, Maag KP. Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease. Am J Ophthalmol 2002; 133:135-7.
7. Vickers JC, Craig JE, Stankovich J, McCormack GH, West AK, Dickinson JL, McCartney PJ, Coote MA, Healey DL, Mackey DA. The apolipoprotein epsilon4 gene is associated with elevated risk of normal tension glaucoma. Mol Vis 2002; 8:389-93 .
8. Ressiniotis T, Griffiths PG, Birch M, Keers S, Chinnery PF. The role of apolipoprotein E gene polymorphisms in primary open-angle glaucoma. Arch Ophthalmol 2004; 122:258-61.
9. Copin B, Brezin AP, Valtot F, Dascotte JC, Bechetoille A, Garchon HJ. Apolipoprotein E-promoter single-nucleotide polymorphisms affect the phenotype of primary open-angle glaucoma and demonstrate interaction with the myocilin gene. Am J Hum Genet 2002; 70:1575-81.
10. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990; 31:545-8.
11. Wenham PR, Price WH, Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991; 337:1158-9.
12. Bunce C, Hitchings RA, Bhattacharya SS, Lehmann OJ. Single-nucleotide polymorphisms and glaucoma severity. Am J Hum Genet 2003; 72:1593-4; author reply 1594-5.
13. Lambert JC, Pasquier F, Cottel D, Frigard B, Amouyel P, Chartier-Harlin MC. A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease. Hum Mol Genet 1998; 7:533-40.
14. Kumar T, Liestol K, Maehlen J, Hiorth A, Jettestuen E, Lind H, Brorson SH. Allele frequencies of apolipoprotein E gene polymorphisms in the protein coding region and promoter region (-491A/T) in a healthy Norwegian population. Hum Biol 2002; 74:137-42.